186 related articles for article (PubMed ID: 18712686)
21. How vaccines are developed.
Douglas RG
Curr Clin Top Infect Dis; 1994; 14():192-204. PubMed ID: 8086115
[No Abstract] [Full Text] [Related]
22. Errors in 'Trials and error'.
Miller DD
Nat Biotechnol; 2006 Jul; 24(7):747. PubMed ID: 16841048
[No Abstract] [Full Text] [Related]
23. Untying the Gordian knot.
Su F; Zuppa AF; Adamson PC
Anesth Analg; 2007 Apr; 104(4):993; author reply 993-4. PubMed ID: 17377125
[No Abstract] [Full Text] [Related]
24. Researchers left to guess at outcomes of most cancer clinical trials.
Twombly R
J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774
[No Abstract] [Full Text] [Related]
25. Drug development: more science, more education.
Aronson JK
Br J Clin Pharmacol; 2005 Apr; 59(4):377-8. PubMed ID: 15801930
[No Abstract] [Full Text] [Related]
26. Academia given a helping hand in drug development.
Branca MA
Nat Rev Drug Discov; 2006 Mar; 5(3):177. PubMed ID: 16557654
[No Abstract] [Full Text] [Related]
27. "Getting the dose right": facts, a blueprint, and encouragements.
Peck CC; Cross JT
Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
[No Abstract] [Full Text] [Related]
28. Food and Drug Administration: 100 years of protection.
Mosocco DJ
Home Healthc Nurse; 2007 Mar; 25(3):148-50. PubMed ID: 17353704
[No Abstract] [Full Text] [Related]
29. How to access and process FDA drug approval packages for use in research.
Turner EH
BMJ; 2013 Oct; 347():f5992. PubMed ID: 24126858
[No Abstract] [Full Text] [Related]
30. Pediatric clinical trials: shall we take a lead?
Schreiner MS; Greeley WJ
Anesth Analg; 2002 Jan; 94(1):1-3. PubMed ID: 11772791
[No Abstract] [Full Text] [Related]
31. The special treatment.
Osborne R
Nat Biotechnol; 2008 May; 26(5):487-9. PubMed ID: 18464770
[No Abstract] [Full Text] [Related]
32. Finding value in the U.S. Food and Drug Administration's Fast Track program.
Reichert JM; Rochon SL; Zhang BD
Drug News Perspect; 2009; 22(1):53-8. PubMed ID: 19209299
[TBL] [Abstract][Full Text] [Related]
33. What's in the pipeline.
Glazer WM
Behav Healthc; 2007 Dec; 27(12):19-21. PubMed ID: 18429587
[No Abstract] [Full Text] [Related]
34. Reviews of new drugs.
Miller JL
Clin Pharm; 1993 Apr; 12(4):306. PubMed ID: 8458182
[No Abstract] [Full Text] [Related]
35. A piece of history.
Nat Biotechnol; 2003 Aug; 21(8):831. PubMed ID: 12894179
[No Abstract] [Full Text] [Related]
36. Trouble at the office.
Allison M
Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
[No Abstract] [Full Text] [Related]
37. Dynavax trial halted.
DeFrancesco L
Nat Biotechnol; 2008 May; 26(5):484. PubMed ID: 18464766
[No Abstract] [Full Text] [Related]
38. Uncertainty surrounds cancer vaccine review at FDA.
Fox JL
Nat Biotechnol; 2007 Aug; 25(8):827-8. PubMed ID: 17687346
[No Abstract] [Full Text] [Related]
39. Oncology's first Phase 0 trial.
Rowan K
J Natl Cancer Inst; 2009 Jul; 101(14):978-9. PubMed ID: 19584322
[No Abstract] [Full Text] [Related]
40. Market watch: Upcoming market catalysts in Q2 2014.
Lau J
Nat Rev Drug Discov; 2014 Apr; 13(4):249. PubMed ID: 24658310
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
